| Literature DB >> 28684274 |
Muhammad Kalim1, Jie Chen1, Shenghao Wang1, Caiyao Lin1, Saif Ullah1, Keying Liang1, Qian Ding1, Shuqing Chen2, Jinbiao Zhan3.
Abstract
Programmed cell death 1 ligand 1 (PD-L1) is a trans-membrane protein highly expressed on the membrane of cancer cell, which binds inhibitory receptor of PD-1 on the T cells and attenuates anti-tumor immune response.The strategy of blocking PD1 and PD-L1 interaction has been widely used for anti-cancer drug development. The DNA encoding extracellular domain of PD-L1 was cloned and expressed with the pET30(+) and Escherichia coli BL21(DE3) system. Cloning of PD-L1 extracellular domain was confirmed by PCR and enzymatic digestion. Sequence analysis of cloned targeted genes showed 100% homology of original sequence. The recombinant protein was expressed using 1mM/mL IPTG and purified by affinity chromatography on a column of Ni-NTA and confirmed by SDS-PAGE and western blot analysis. Results showed that our constructed pET30(+)/PDL1-ECD system efficiently produces desired recombinant protein with molecular weight of 38.1kDa. The prokaryotic expression system provides an easy method to express PD-L1 extracellular domain that further facilitate the role of PD-1/PD-L1 binding inhibition and helps in valuable drug and antibodies production.Entities:
Keywords: Antibody; CD274; Expression; Immunotherapy; PD-1; PD-L1
Mesh:
Substances:
Year: 2017 PMID: 28684274 DOI: 10.1016/j.imlet.2017.06.004
Source DB: PubMed Journal: Immunol Lett ISSN: 0165-2478 Impact factor: 3.685